Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir injection for mild to moderate influenza (Phase III, China)
CTR20140865Phase 3Active
- Sponsor
- Tianjin Taipu Pharmaceutical Technology Development Co., Ltd.
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of peramivir in influenza, sponsored by Tianjin Taipu Pharmaceutical Technology Development Co., Ltd.. Started Dec 2014; status: active.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20140865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140865.